Connor, Clark & Lunn Investment Management Ltd. Puma Biotechnology, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$28.9 Billion
Q3 2025

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 943,472 shares of PBYI stock, worth $4.67 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

943,472

Previous 900,256 4.8%

Holding current value

$4.67 Million

Previous $3.09 Million 56.79%

% of portfolio

0.02%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$3.07 - $5.73 $132,673 - $247,627	43,216 Added 4.8%	943,472 $4.84 Million
Q2 2025 Aug 07, 2025	BUY	$2.74 - $3.72 $187,873 - $255,069	68,567 Added 8.24%	900,256 $3.09 Million
Q1 2025 May 12, 2025	BUY	$2.76 - $3.88 $950,325 - $1.34 Million	344,321 Added 70.65%	831,689 $2.46 Million
Q4 2024 Feb 10, 2025	BUY	$2.42 - $3.39 $287,769 - $403,115	118,913 Added 32.27%	487,368 $1.49 Million
Q3 2024 Nov 08, 2024	BUY	$2.25 - $4.03 $31,367 - $56,182	13,941 Added 3.93%	368,455 $939,000

Q2 2024 Aug 09, 2024	SELL	$2.92 - $5.83 $91,539 - $182,764	-31,349 Reduced 8.12%	354,514 $1.16 Million
Q1 2024 May 09, 2024	BUY	$4.29 - $7.4 $811,685 - $1.4 Million	189,204 Added 96.21%	385,863 $2.05 Million
Q4 2023 Feb 09, 2024	SELL	$2.23 - $4.49 $6,930 - $13,954	-3,108 Reduced 1.56%	196,659 $851,000
Q2 2023 Aug 10, 2023	BUY	$2.6 - $3.58 $41,137 - $56,642	15,822 Added 8.6%	199,767 $705,000
Q1 2023 May 09, 2023	BUY	$2.21 - $4.82 $1,491 - $3,253	675 Added 0.37%	183,945 $568,000
Q4 2022 Feb 10, 2023	BUY	$2.12 - $5.08 $72,029 - $172,598	33,976 Added 22.76%	183,270 $775,000
Q3 2022 Nov 10, 2022	BUY	$2.27 - $3.84 $162,765 - $275,339	71,703 Added 92.41%	149,294 $354,000
Q2 2022 Aug 05, 2022	SELL	$1.64 - $3.3 $21,549 - $43,362	-13,140 Reduced 14.48%	77,591 $221,000
Q1 2022 May 12, 2022	SELL	$2.13 - $3.24 $20,200 - $30,728	-9,484 Reduced 9.46%	90,731 $261,000
Q4 2021 Feb 10, 2022	BUY	$2.85 - $6.58 $285,612 - $659,414	100,215 New	100,215 $305,000
Q2 2020 Aug 13, 2020	SELL	$7.01 - $13.24 $80,383 - $151,823	-11,467 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$6.28 - $14.57 $72,012 - $167,074	11,467 New	11,467 $96,000

Others Institutions Holding PBYI

# of Institutions

135

Shares Held

35.2M

Call Options Held

264K

Put Options Held

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $226M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. Puma Biotechnology, Inc. Transaction History